GlobeNewswire Inc.··NaAIM ImmunoTech Flags Going Concern Despite Clinical Trial Progress
AIM ImmunoTech disclosed going concern warnings in 2025 audited statements but expressed confidence in fundraising backed by promising Ampligen-Imfinzi trial results.
AZNAIMPhase 2 clinical trialfundraising